AVP and Hyponatremia: After ruling out other etiologies of euvolemic hyponatremia, it was hypothesized that the lipophilic properties of ciprofloxacin enable it to cross the blood–brain barrier, allowing ciprofloxacin to bind to glutamate receptors and stimulate ADH release.